Phase 3 Randomized, Double-blind Study Of The Efficacy And Safety Of 2 Doses Of Cp-690,550 Compared To Methotrexate In Methotrexate Navie Patients With Rheumatoid Arthritis
Phase 3 Randomized, Double-blind Study Of The Efficacy And Safety Of 2 Doses Of Cp-690,550 Compared To Methotrexate In Methotrexate Navie Patients With Rheumatoid Arthritis
This study is designed to compare the effectiveness of the experimental drug, CP-690,550, to methotrexate in preventing joint damage and improving symptoms of rheumatoid arthritis. This study will also compare the safety of CP-690,550 with methotrexate.
Inclusion Criteria:
Exclusion Criteria:
La Jolla, California 92037-0943, United States
La Jolla, California 92093 0943, United States
Gainesville, Florida 32607, United States
Charleston, South Carolina 29425, United States
São Paulo, São Paulo 04266-010, Brazil
Sofia, 1606, Bulgaria
Veliko Tarnovo, 5000, Bulgaria
Bogota, Cundinamarca 0000, Colombia
Ostrava-Poruba, 70800, Czechia
Hyderabad, Andhra Pradesh 500 004, India
Secunderabad, Andhra Pradesh 500003, India
Otahuhu, Auckland 1640, New Zealand
Christchurch, 8022, New Zealand
Lima, L-27, Peru
Davao City, 8000, Philippines
Novosibirsk, 630055, Russia
Novosibirsk, 630117, Russia
Saint Petersburg, 190068, Russia
Saint Petersburg, 194291, Russia
Saint Petersburg, 197706, Russia
Saint Petersburg, 198260, Russia
Smolensk, 214019, Russia
Seoul, 120-752, South Korea
Phayathai, Bangkok 10400, Thailand
Simferopol, Autonomous Republic of Crimea 95017, Ukraine
Kyiv, 04053, Ukraine
Kyiv, 04114, Ukraine
Odesa, 65026, Ukraine